Expanding the spectrum of recombination-activating gene 1 deficiency: A family with early-onset autoimmunity - 27/09/13
Doi : 10.1016/j.jaci.2013.06.032
Lauren A. Henderson, MD a, ∗, Francesco Frugoni, MS a, ∗, Gregory Hopkins, BS b, Helen de Boer, BAS b, Sung-Yun Pai, MD b, c, Yu Nee Lee, PhD a, Jolan E. Walter, MD, PhD a, d, Melissa M. Hazen, MD a 
, Luigi D. Notarangelo, MD a, e, f
, Luigi D. Notarangelo, MD a, e, f a Division of Immunology, Boston Children's Hospital, Boston, Mass
b Division of Hematology and Oncology, Boston Children's Hospital, Boston, Mass
e Manton Center For Orphan Disease Research, Boston Children's Hospital, Boston, Mass
c Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Mass
d Division of Pediatric Allergy/Immunology, Massachusetts General Hospital for Children, Boston, Mass
f Harvard Stem Cell Institute, Boston, Mass
| Supported in part by the National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) grant 5P01AI076210-04 (to L.D.N.), NIAID/NIH grant U54AI082973 (to S.-Y.P and L.D.N.), the Manton Foundation (to S.-Y.P and L.D.N.), March of Dimes grant 1-FY13-500, the Jeffrey Modell Foundation (to L.D.N.), and the Translational Investigator Service, Boston Children's Hospital (to S.-Y.P.). |
|
| Disclosure of potential conflict of interest: L. A. Henderson has received grants from the NIH, the Manton Foundation, the March of Dimes, and the Jeffrey Modell Foundation and has received travel support from the American College of Rheumatology. G. Hopkins has received grants from the NIH, the NIAID, the Manton Foundation, the March of Dimes, and the Translational Investigator Service. H. de Boer has received grants from the NIH, the Manton Foundation, the March of Dimes, and the Jeffrey Modell Foundation. S.-Y. Pai has received grants from the NIH/NIAID; the National Heart, Lung, and Blood Institute; and the Manton Foundation and has received a Boston Children's Hospital internal award for Translational Investigator Service for salary. Y. N. Lee has received a grant from the Manton Center. J. E. Walter has received grants from the NIAID. L. D. Notarangelo has received grants from the NIH, the March of Dimes, the Manton Foundation, and the Jeffrey Modell Foundation; is on the scientific advisory boards for the Immune Disease Institute and Meyer Hospital; is employed by Boston Children's Hospital; and receives royalties from UpToDate. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 132 - N° 4
P. 969 - octobre 2013 Retour au numéro
Article précédent
- Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy
- Emilie Collmann, Thomas Bohnacker, Romina Marone, Janet Dawson, Markus Rehberg, Rowan Stringer, Fritz Krombach, Christoph Burkhart, Emilio Hirsch, Gregory J. Hollingworth, Matthew Thomas, Matthias P. Wymann
- IL-13/IL-22–coproducing T cells, a novel subset, are increased in atopic dermatitis
- Yuichi Teraki, Aika Sakurai, Seiichi Izaki
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?